Sangrix
Quarterly Financials
| Values in thousands | 2025-09-30 |
|---|---|
Revenue | $39 |
EBITDA | -1,085 |
Net Income | -1,581 |
Net Change In Cash | 39 |
Free Cash Flow | 634 |
Cash | 55 |
Basic Shares | 196 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $39 | $2,888 | $6,261 |
Gross Profit | 0 | -945 | -4,565 | |
EBITDA | -14,293 | -2,991 | -16,886 | -22,627 |
EBIT | -14,293 | -3,704 | -17,787 | -27,988 |
Net Income | -14,285 | -4,387 | -17,531 | -28,216 |
Net Change In Cash | 0 | 39 | 2,888 | 6,261 |
Free Cash Flow | -2,923 | -2,290 | -7,929 | -6,876 |
Cash | 1,569 | 55 | 1,409 | 16 |
Basic Shares | 747 | 77 | 17 | 10 |